NAVB: Message Board for Navidea Biopharmaceuticals, Inc. - InvestorVillage

Navidea Biopharmaceuticals, Inc.

  NAVB website

  • Not sure what all the "Premium Service" fuss is all about? 

    Watch this 2 minute video to find out.





  • Only 1 Lifetime Premium Membership left




     

NAVB   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 2500 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
30505 Re: 2019: "role of M2 macrophages in atherosclerosis has been linked to plaque regression... M1 macrophage presence in symptomatic patients indicated unstable plaques...foundation for the hypothesis that M1-to-M2 macrophage ratios could be used as a..." GN moneyonomics 0 8/21/2019 2:05:06 AM
30504 2019:Macrophage nuclear receptors ie cd206:Emerging key players in infectious diseases..NRs becoming increasingly appreciated in.. infections; therefore, targeting NRs may provide a new, largely unexplored area for infectious disease treatment" GN moneyonomics 0 8/21/2019 1:19:57 AM
30503 Re: 2019: "role of M2 macrophages in atherosclerosis has been linked to plaque regression... M1 macrophage presence in symptomatic patients indicated unstable plaques...foundation for the hypothesis that M1-to-M2 macrophage ratios could be used as a..." GN RGIII 1 8/20/2019 9:37:02 PM
30502 Re: 2019: "role of M2 macrophages in atherosclerosis has been linked to plaque regression... M1 macrophage presence in symptomatic patients indicated unstable plaques...foundation for the hypothesis that M1-to-M2 macrophage ratios could be used as a..." GN dadeo55 0 8/20/2019 4:32:47 PM
30501 2019: "role of M2 macrophages in atherosclerosis has been linked to plaque regression... M1 macrophage presence in symptomatic patients indicated unstable plaques...foundation for the hypothesis that M1-to-M2 macrophage ratios could be used as a..." GN moneyonomics 2 8/20/2019 2:26:14 PM
30500 2019: "study revealed a progressive increase in CD206-positive macrophages from normal prostate to metastatic CRPC.our results provide a rationale for therapeutic development to deplete these cells in the prostate cancer microenvironment.... GN moneyonomics 2 8/20/2019 2:01:02 PM
30499 Re: For those New to Macrophages: "M1 Means Kill; M2 Means Heal"...Journal of Immunology and Charles D Mills discoverer of M1/M2 GN dadeo55 0 8/20/2019 12:55:04 AM
30498 For those New to Macrophages: "M1 Means Kill; M2 Means Heal"...Journal of Immunology and Charles D Mills discoverer of M1/M2 GN moneyonomics 2 8/19/2019 9:20:46 PM
30497 Re: 2019 study: Targeting Cd206/TAMS now a fast growing field in cancer research as is using Spect imaging "CD206 positive M2-macrophage targeting engineered exosomes as a potential diagnostic and therapeutic tool" GN dadeo55 0 8/19/2019 2:46:50 PM
30496 2019 study: Targeting Cd206/TAMS now a fast growing field in cancer research as is using Spect imaging "CD206 positive M2-macrophage targeting engineered exosomes as a potential diagnostic and therapeutic tool" GN moneyonomics 2 8/19/2019 2:09:23 PM
Previous 2500 Messages Top of Message List
Go to Msg #  


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...